Agriculture, Rural Development, and Related Agencies Appropriations for 1982: Hearings Before a Subcommitee of the Committee on Appropriations, House of Representatives, Ninety-sixth Congress, First Session, Parts 5-6U.S. Government Printing Office, 1981 - United States |
From inside the book
Results 1-5 of 100
Page 26
... effort is a success story . We know that with the cooperative efforts among the producer , USDA , FDA and the drug industry , the level of violative residue in swine tissue has come down , yet swine producers have had the drug available ...
... effort is a success story . We know that with the cooperative efforts among the producer , USDA , FDA and the drug industry , the level of violative residue in swine tissue has come down , yet swine producers have had the drug available ...
Page 33
... efforts , an error is made and people die , or get seriously ill , not from the lack of the drug but because the preclinical or clinical trials did not reveal some serious side effect . It is a very difficult judgment for a medical ...
... efforts , an error is made and people die , or get seriously ill , not from the lack of the drug but because the preclinical or clinical trials did not reveal some serious side effect . It is a very difficult judgment for a medical ...
Page 97
... efforts was on better management of the review system and the reviewing staff . Innova- tions during the past eight years have included , for example , reor- ganization of the reviewing divisions into drug class groups , the ...
... efforts was on better management of the review system and the reviewing staff . Innova- tions during the past eight years have included , for example , reor- ganization of the reviewing divisions into drug class groups , the ...
Page 97
... efforts was on better management of the review system and the reviewing staff . Innova- tions during the past eight years have included , for example , reor- ganization of the reviewing divisions into drug class groups , the ...
... efforts was on better management of the review system and the reviewing staff . Innova- tions during the past eight years have included , for example , reor- ganization of the reviewing divisions into drug class groups , the ...
Page 100
... efforts by the National Institutes of Health . DRUG DEVELOPMENT COSTS Mr. WHITTEN . You state that the drug industry claims that the total cost of developing a new drug today ranges between $ 50-80 million , but that , for a number of ...
... efforts by the National Institutes of Health . DRUG DEVELOPMENT COSTS Mr. WHITTEN . You state that the drug industry claims that the total cost of developing a new drug today ranges between $ 50-80 million , but that , for a number of ...
Other editions - View all
Common terms and phrases
action activities additional aflatoxin agency agency's amended ampicillin analysis analyzed animal drugs appropriate approval approximately benzodiazepines blood budget Bureau carcinogen chemical cimetidine clinical Committee commodities compliance Conduct consumer contamination cosmetic costs determine digoxin dispensers distribution dose Drug Administration Drug Applications effects established Estimated evaluation facilities FDA's Federal Register feed Food and Drug Food Safety FSQS funds HOUSTON human implementation increase industry initial inspection investigations laboratory manufacturers meat and poultry medical devices ment methods methoxsalen million monitoring NOVITCH orphan drugs patient package inserts percent personnel pesticide petition pharmacists pharmacy phenytoin potential POULTRY PRODUCTS PPIs prescription drug problems procedures proposed radiation regulations regulatory reports request requirements response revised risk samples scientific September 12 Service SODIUM specific standards submitted testing thiazide tion toxic Toxicology USDA vaccines warfarin WHITTEN